23andMe Begins Reporting Three SNPs for Warfarin Sensitivity; Plans to Study Others

By offering SNP data on warfarin sensitivity, 23andMe may be gearing up to recruit participants for future research projects seeking new gene associations and the clinical utility of pharmacogenomics-guided warfarin dosing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.